Encephalitis and catatonia treated with ECT

Cognitive and Behavioral Neurology

Volumn 21, Issue 1, 2008, Pages 46-51

  Ali, Sherese ^a   Welch, Charles A ^d,f   Park, Lawrence T ^c,f   Pliakas, Andrea M ^d,e   Wilson, Amanda ^d   Nicolson, Stephen ^d   Huffman, Jeff ^d,f   Fricchione, Gregory L ^b,f  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Division of Psychiatry   (United States)

^c Inpatient Psychiatry   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MCLEAN HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Electroconvulsive therapy; Encephalitis; Malignant catatonia

Indexed keywords

ACICLOVIR; AMANTADINE; ANTIBIOTIC AGENT; BENZATROPINE; CARBAMAZEPINE; ETIRACETAM; FAMCICLOVIR; GABAPENTIN; HALOPERIDOL; LORAZEPAM; METHYLPREDNISOLONE SODIUM SUCCINATE; OLANZAPINE; PHENYTOIN; PREDNISONE; PROPOFOL; QUETIAPINE; VALPROIC ACID;

ADULT; AGITATION; ANAMNESIS; ARTICLE; CASE REPORT; CATATONIA; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; HUMAN; LABORATORY TEST; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; RASH; SEIZURE; TREATMENT RESPONSE;

ADULT; CATATONIA; CEREBROSPINAL FLUID; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTOSIS; MENTAL STATUS SCHEDULE; NEUROLOGIC EXAMINATION; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS;

EID: 40449109728     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e318168464a     Document Type: Article

References (28)

1. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261-271.
2. Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78:381-385.
3. Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380-386.
4. Howard RS, Lees AJ. Encephalitis lethargica: a report of four recent cases. Brain. 1987;110:19-33.
5. Wharton R. Encephalitis lethargica a literature review. 2003 Available at: http://www.thesophiecamerontrust.org.uk/research/el_literature_review.pdf
6. Shill HA, Stacy MA. Malignant catatonia secondary to sporadic encephalitis lethargica. J Neurol Neurosurg Psychiatry. 2000;69:402-403.
7. Verschueren H, Crols R. Bilateral substantia nigra lesions on magnetic resonance imaging in a patient with encephalitis lethargica. J Neurol Neurosurg Psychiatry. 2001;71:275.
8. Kun LN, Yian SY, Haur LS, et al. Bilateral substantia nigra changes on MRI in a patient with encephalitis lethargica. Neurology. 1999;53:1860-1862.
9. Dale RC, Church AJ, Surtees RAH, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004;127:21-33.
10. Bush G, Fink M, Petrides G, et al. Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-136.
11. Fink M, Taylor MA. Catatonia. A Clinician's Guide to Diagnosis and Treatment. Cambridge, UK: Cambridge University Press; 2003:130, 158-159, 160.
12. Mortimer AM. Standardized instruments. In: Caroff SN, Mann SC, Francis A, et al. Catatonia. From Psychopathology to Neurobiology. Arlington, Virginia: American Psychiatric Publishing Inc; 2004:53-62.
13. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci. 1994;6:1-13.
14. Van Den Eede F, Van Hecke J, Van Dalfsen A, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry. 2005;20:422-429.
15. Carroll BT. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr. 2000;5:26-33.
16. Koch M, Chandragiri S, Rizvi S, et al. Catatonic signs in neuroleptic malignant syndrome. Compr Psychiatr. 2000;41:73-75.
17. White D, Robins A. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS Spectr. 2000;5:58-65.
18. Rosebush PI, Mazurek MF. Pharmacotherapy. In: Caroff SN, Mann SC, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Arlington, Virginia: American Psychiatric Publishing Inc; 2004:146.
19. Mann SC, Caroff SN, Fricchione GL, et al. Malignant catatonia. In: Caroff SN, Mann SC, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Arlington, Virginia: American Psychiatric Publishing Inc; 2004:115-116.
20. Petrides G, Malur C, Fink M. Convulsive therapy. In: Caroff SN, Mann SC, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Arlington, Virginia: American Psychiatric Publishing Inc; 2004:151-161.
21. Mann SC, Caroff SN, Bleier HR, et al. Electroconvulsive therapy of the lethal catatonia syndrome. Convuls Ther. 1990;6:239-247.
22. Dekleva KB, Husain MM. Sporadic encephalitis lethargica: a case treated successfully with ECT. J Neuropsychiatry Clin Neurosci. 1995;7:237-239.
23. Slooter AJC, Braun KPJ, Balk FJE, et al. Electroconvulsive therapy for malignant catatonia in childhood. Paediatr Neurol. 2005;32:190-192.
24. Raghav S, Seneveratne J, McKelvie PA, et al. Sporadic encephalitis lethargica. J Clin Neurosci. 2007;14:696-700.
25. Blunt SB, Lane RJM, Turjanski N, et al. Clinical features and management of two cases of encephalitis lethargica. Mov Disord. 1997;12:354-359.
26. Triarhou LC. The percipient observations of Constantin von Economo on encephalitis lethargica and sleep disruption and their lasting impact on contemporary sleep research. Brain Res Bull. 2006;69:244-258.
27. Fricchione GL, Bush G, Fozdar M, et al. Recognition and treatment of the catatonic syndrome. J Intensive Care Med. 1997;12:135-147.
28. Dickman MS. von Economo Encephalitis. Arch Neurol. 2001;58:1696-1698.